These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38727213)

  • 1. Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase.
    Moore HP; Palumbo PJ; Notarte KI; Fogel JM; Cummings V; Gamble T; Del Rio C; Batey DS; Mayer KH; Farley JE; Remien RH; Beyrer C; Hudelson SE; Eshleman SH;
    J Clin Microbiol; 2024 Jun; 62(6):e0013624. PubMed ID: 38727213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
    Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
    J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of an
    Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
    Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
    Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 genotyping of the protease-reverse transcriptase and integrase genes to detect mutations that confer antiretroviral resistance.
    Van den Eede P; Van Wesenbeeck L; Verlinden Y; Feyaerts M; Smits V; Verheyen A; Vanhooren L; Deloof A; Villacian J; Pattery T
    Methods Mol Biol; 2013; 1030():37-55. PubMed ID: 23821259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of drug resistance against protease, reverse transcriptase, and integrase inhibitors by next-generation sequencing in HIV-positive patients.
    Tekin D; Gokengin D; Onay H; Erensoy S; Sertoz R
    J Med Virol; 2021 Jun; 93(6):3627-3633. PubMed ID: 33026651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance Testing.
    Weber J; Volkova I; Sahoo MK; Tzou PL; Shafer RW; Pinsky BA
    J Mol Diagn; 2019 Nov; 21(6):961-970. PubMed ID: 31382033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
    Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
    J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
    Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
    J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of the TRUGENE HIV-1 genotyping kit.
    Grant RM; Kuritzkes DR; Johnson VA; Mellors JW; Sullivan JL; Swanstrom R; D'Aquila RT; Van Gorder M; Holodniy M; Lloyd RM; Reid C; Morgan GF; Winslow DL
    J Clin Microbiol; 2003 Apr; 41(4):1586-93. PubMed ID: 12682149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform.
    Gholami M; Rouzbahani N; Samiee S; Tayeri K; Ghorban K; Dehkharghani AD; Gholami AA; Moshiri F; Sattari A; Dadmanesh M; Mohraz M
    Microb Pathog; 2020 Sep; 146():104221. PubMed ID: 32360523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
    Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
    J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer.
    Eshleman SH; Crutcher G; Petrauskene O; Kunstman K; Cunningham SP; Trevino C; Davis C; Kennedy J; Fairman J; Foley B; Kop J
    J Clin Microbiol; 2005 Feb; 43(2):813-7. PubMed ID: 15695685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations.
    Biba C; Fiaschi L; Varasi I; Paletti C; Bartolini N; Zazzi M; Vicenti I; Saladini F
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance.
    Raymond S; Nicot F; Abravanel F; Minier L; Carcenac R; Lefebvre C; Harter A; Martin-Blondel G; Delobel P; Izopet J
    J Clin Virol; 2020 Jan; 122():104229. PubMed ID: 31809945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System.
    Kuritzkes DR; Grant RM; Feorino P; Griswold M; Hoover M; Young R; Day S; Lloyd RM; Reid C; Morgan GF; Winslow DL
    J Clin Microbiol; 2003 Apr; 41(4):1594-9. PubMed ID: 12682150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 genotypic resistance testing using single molecule real-time sequencing.
    Raymond S; Jeanne N; Vellas C; Nicot F; Saune K; Ranger N; Latour J; Carcenac R; Harter A; Delobel P; Izopet J
    J Clin Virol; 2024 Oct; 174():105717. PubMed ID: 39068746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
    May S; Adamska E; Tang J
    J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples.
    Cunningham S; Ank B; Lewis D; Lu W; Wantman M; Dileanis JA; Jackson JB; Palumbo P; Krogstad P; Eshleman SH
    J Clin Microbiol; 2001 Apr; 39(4):1254-7. PubMed ID: 11283037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.
    Raymond S; Nicot F; Carcenac R; Lefebvre C; Jeanne N; Saune K; Delobel P; Izopet J
    J Antimicrob Chemother; 2018 May; 73(5):1152-1157. PubMed ID: 29444253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.